Prediction Case File
YouTubeTracking Live

Endlich! Xpeng liefert!

1 extracted signal · 0 resolved · 1 still active

DER-RENTNER | BÖRSE & KRYPTO profile imageDER-RENTNER | BÖRSE & KRYPTOIndependent analyst profile
Source published
16 Nov 2026, 16:00 UTC
Recorded by Tahlil Plus
16 Nov 2026, 16:33 UTC
Video preview for Endlich! Xpeng liefert!
Source overview

AI-generated source summary

Xpeng (XPEV) is analyzed based on strong fundamental Q3 delivery growth and an Elliott wave technical structure indicating a potential bullish reversal. Following a multi-wave correction, the price is projected to target the 29 to 42 US dollar region, supported by positive RSI and MACD divergences on the daily chart. An invalidation level is set below 6.56 US dollars.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

DER-RENTNER | BÖRSE & KRYPTO

Platform-wide history, separate from this source evaluation.

Reliability
56.8
Tracked signals
115
Historical success
47.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail